PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2005 | 4 | 7-27
Article title

Therapeutic and market expectancy of recombinant medicines

Content
Title variants
Languages of publication
PL
Abstracts
EN
Therapeutic applications and global market of commercialized biopharmaceuticals-recombinant medicines have been presented. The first and second generation of genetically engineered products such as: hormones, cytokines, blood factors, monoclonal antibodies and others approved to date or undergoing clinical investigations in the US and EU have been described. They are used to treat or prevent many diseases, including: diabetes, growth deficiency, anemia, cardio-vascular disorders and, especially, immune-mediated inflammatory disorders and various cancers. The authors have also presented current global biopharmaceutical market, leading biopharmaceuticals, the fastest growing recombinant protein categories and strategic market analysis and forecasts until 2010.
Journal
Year
Issue
4
Pages
7-27
Physical description
References
Document Type
REVIEW
Publication order reference
Maria Jarecka, Instytut Biotechnologii i Antybiotykow, ul. Staroscinska 5, 02-516 Warszawa, Poland
YADDA identifier
bwmeta1.element.element-from-psjc-e3ee6634-ed62-3a16-ad70-a7d05981a6dc
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.